Free Trial
CVE:NVV

Norvista Capital (NVV) Stock Price, News & Analysis

C$0.08
-0.01 (-6.25%)
(As of 01/12/2022)

About Norvista Capital Stock (CVE:NVV)

Key Stats

Today's Range
C$0.08
C$0.08
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.07
C$0.23
Volume
112,500 shs
Average Volume
116,000 shs
Market Capitalization
C$5.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Norvista Capital Corporation operates as a resource investment company and merchant bank in the United States and Canada. It invests in a portfolio of companies that are involved in the exploration of base and precious metals, such as copper, zinc, silver, gold, and lead, as well as oil and gas located in Chile, Manitoba, Yukon, Mexico, and Nevada; and oil and gas in Israel, the United States, Brazil, and Canada. The company was founded in 2014 and is headquartered in Toronto, Canada.

Receive NVV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Norvista Capital and its competitors with MarketBeat's FREE daily newsletter.

NVV Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
See More Headlines

NVV Stock Analysis - Frequently Asked Questions

Norvista Capital's stock was trading at C$0.08 on January 1st, 2024. Since then, NVV shares have increased by 0.0% and is now trading at C$0.08.
View the best growth stocks for 2024 here
.

Shares of NVV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Norvista Capital investors own include Matinas BioPharma (MTNB), Advanced Micro Devices (AMD), Altimmune (ALT), Albireo Pharma (ALBO), Alliance Data Systems (ADS), AcelRx Pharmaceuticals (ACRX) and Albertsons Companies (ACI).

Industry, Sector and Symbol

Industry
Industrial Metals & Minerals
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
1,990
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$-1,274,069.00
Cash Flow
C$0.12 per share
Book Value
C$0.11 per share

Miscellaneous

Free Float
N/A
Market Cap
C$5.26 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (CVE:NVV) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners